The observations that high-dose dopamine agonists can induce or potentiate psychotic symptoms and that dopamine D2 receptor blockade has antipsychotic effects are foundational elements of the modern understanding of schizophrenia neurobiology [5, 6]. This evidence concerns the gene DRD2 and schizophrenia.